Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Sermorelin vs CJC-1295 (No DAC) — Peptide Comparison

Sermorelin vs CJC-1295 (No DAC) — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

At a Glance

Quickcomparison

Dose Range

Sermorelin

100–300 mcg

CJC-1295 (No DAC)

Frequency

Once daily

Administration

Subcutaneous injection

Cycle Length

12+ weeks

8-12 weeks

Onset Speed

Moderate (1-2 weeks)

Evidence Level

Moderate human trials (Phase 1-2)

Efficacy

Benefitratings

GH Optimization

Sleep Quality

Body Composition

GH Stimulation

Recovery Support

Technical Data

Compoundspecifications

Molecular Formula

C149H246N44O42S

Molecular Weight

3357.9 g/mol

Half-Life

10-20 minutes

Bioavailability

High when injected subcutaneously; degraded orally

CAS Number

86168-78-7

C152H252N44O42

3367.9 g/mol

30 minutes to 2 hours

~100% (subcutaneous)

863288-34-0

Protocols

Dosingtiers

starting

100-200 mcg

Once daily at bedtime

4-6 weeks

Lower nightly dose used in practice; GHRH(1-29) nightly injections raised GH/IGF-1 in older adults [2][3].

standard

200-300 mcg

3-6 months

Common adult maintenance dose; twice-daily GHRH(1-29) reversed age-related GH/IGF-1 decline in men [1][2].

100 mcg

Once daily, 30 minutes before bed

2-4 weeks

A common starting dose used in research practice. Because the no-DAC form is short-acting (about 30 minute half-life), it is injected on an empty stomach for the best growth-hormone pulse. [1]

100 mcg per dose

1-2 times daily

The typical maintenance dose used in practice, often given before bed and/or after fasted exercise. Frequently paired with a GH-releasing peptide. [1]

advanced

2-3 times daily

A higher-frequency plan used by experienced users to mimic natural GH pulses across the day, each dose taken fasted. [1]

Applications

Bestsuited for

Adults Experiencing Age-Related GH Decline

After age 30, your growth hormone production naturally declines about 14% per decade. Sermorelin helps restore more youthful GH levels by stimulating your own pituitary rather than shutting it down with external hormones. It's like giving your hormone system a gentle nudge back to where it used to be.

Body Composition Optimizers

If you're struggling to lose stubborn belly fat or build lean muscle despite diet and exercise, sermorelin can help shift your body composition over time. Studies show it increases lean mass and reduces fat, especially in older adults whose natural GH has declined.

Sleep Quality Seekers

Growth hormone is intimately tied to deep, restorative sleep. By enhancing your natural nighttime GH pulses, sermorelin often improves sleep quality as a welcome side effect. Many users report falling asleep faster and waking more refreshed.

Those Wanting a Safer Alternative to HGH

Direct HGH injections bypass your body's feedback system and can suppress your own production. Sermorelin works differently—it asks your pituitary to make more GH naturally. This preserves your body's regulatory mechanisms and carries a lower risk of side effects.

Natural Growth Hormone Optimization

Perfect for those wanting to boost their body's own GH production rather than using synthetic growth hormone. Mimics the natural pulsatile release pattern your pituitary uses.

Workout Recovery and Muscle Building

Athletes and fitness enthusiasts use it to accelerate recovery between training sessions, support lean muscle development, and reduce body fat over time.

Sleep Quality Enhancement

Because GH is naturally released during deep sleep, many users report dramatically improved sleep quality with more vivid dreams and feeling more refreshed upon waking.

Anti-Aging and Vitality

As GH levels decline with age, CJC-1295 helps restore more youthful hormone patterns, potentially improving skin quality, energy levels, and overall well-being.

Synergistic Peptide Stacking

Designed to work hand-in-hand with GHRPs like Ipamorelin. When combined, these peptides amplify each other's effects for significantly greater GH release than either alone.

Safety Profile

Sideeffects

Common

Injection site reactions

Facial flushing

Headache

Sleepiness or drowsiness

Uncommon

Nausea

Hyperactivity or difficulty sleeping

Serious

Severe allergic reaction

Flushing or warmth

Water retention

Increased appetite

Tingling or numbness

Allergic reaction

Research Status

Safety& evidence

FDA Status

FDA approved for other use

Safety Overview

Sermorelin has an excellent safety profile backed by FDA approval history and decades of clinical use. Unlike direct HGH, it works through your body's natural feedback mechanisms, which inherently limits excessive hormone levels. Side effects are generally mild and transient—mostly injection site reactions and occasional flushing. The peptide was FDA-approved in 1997 for pediatric use and is one of the most well-studied growth hormone secretagogues available.

Contraindications

xActive cancer or history of cancer

xPregnancy or breastfeeding

xKnown allergy to sermorelin or any peptide components

xPituitary tumors or other pituitary disorders

xDiabetic retinopathy

Research compound

CJC-1295 without DAC has been studied in Phase 1-2 human clinical trials with a favorable safety profile. The most common side effects are mild and include injection site reactions and temporary flushing. Because it stimulates natural GH release rather than providing exogenous GH, it maintains the body's feedback mechanisms.

xPituitary tumors or disorders

xHypersensitivity to GHRH analogs

Decision Guide

Which isright for you?

Choose Sermorelin if...

Anti-aging and vitality

Body composition improvement

Sleep quality enhancement

Exercise recovery

Choose CJC-1295 (No DAC) if...

Increasing natural growth hormone levels

Building lean muscle mass

Improving sleep quality

Enhancing workout recovery

Connected topics

Follow this recovery question